[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ardx
Ardelyx stock surges on strong Q3 earnings and positive analyst ratings, with significant revenue growth reported for IBSRELA. The company also unveiled its next-generation NHE3 inhibitor, RDX10531, boosting pipeline development prospects.
About $ardx
Ardelyx is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with chronic diseases.
Insights
- $ardx sentiment near a 52-week low at X.
- $ardx engagements is up XXXXX% from the previous week.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +36%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-01-23
1-Year Low: XX on 2025-09-24
Engagements by network (24h): Reddit: X X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +18%
X Months: XXXXX +13%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-01-06
1-Year Low: X on 2025-09-22
Mentions by network (24h): Reddit: X X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $ardx in the last XX hours which is no change from in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +82%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-22
The most influential creators that mention $ardx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @NightOwlBiotech | X | XXXXX | X | XXX |
| @Market_Mentor01 | X | XX | X | XX |
| @Trader_House04 | X | XX | X | XX |
| @Oddhootcapital | X | XXX | X | X |
Sentiment: X%
Sentiment 24-Hour Time-Series Raw Data
Current Value: X%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-16
1-Year Low: XX% on 2025-12-10
Most Supportive Themes:
- Positive Earnings and Guidance: (30%) Ardelyx reported strong Q3 earnings, beating expectations with significant revenue growth for IBSRELA and raising full-year guidance. Analysts are positive, with some reiterating Buy ratings and price targets.
- Pipeline Development: (25%) Ardelyx announced the development of RDX10531, a next-generation NHE3 inhibitor, signaling a potential second growth wave with new intellectual property protection. This pipeline expansion is seen as a key long-term value driver.
- Analyst Upgrades and Positive Sentiment: (20%) Multiple analysts have issued positive ratings and price target increases for ARDX, citing strong sales performance and pipeline potential. Social media sentiment is largely bullish, with many posts highlighting the stock as a top gainer or a strong buy.
Most Critical Themes:
- XPHOZAH Access Challenges: (15%) Despite strong performance in other areas, there are ongoing concerns regarding reimbursement and access for XPHOZAH, which could impact future revenue and margins.
Top $ardx Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ARDX $ARE ⚠👀 Guys Don't miss the next move in a few hours 💸➡"
X Link @Signal_Trader09 2025-12-11T13:04Z XX followers, XX engagements
"$ardx is in inverted head and shoulders pattern. Same as $ms when I bought it at $XX. Regretfully didn't have patience and sold at $XX. Holding till reaches $XX in 6-9 months. As well as $sofi but will hold much longer"
X Link @ViktorFrux 2025-12-10T07:31Z XXX followers, XXX engagements
"Top X Bullish Sentiment Cryptos: CROWD 🟩 $FCH $ARDX $BGL Check out sentiment and other crypto stats at"
X Link @MarketProphit 2025-12-10T05:05Z 69.9K followers, XXX engagements
"$ARDX China approval is good milestone & could wreck shorts and hopefully will. Should be a good week. Will have a nice PR soon and then analyst upgrades. Tuesday drug list interpretation. Not any advice but buying any dips hand over fist is a Christmas gift as is anything under $X. This will work its way to double digits. Profitable with drug approved for X indications. Good financial fundamentals. Confident"
X Link @crypto_biotech 2025-12-07T16:22Z 4787 followers, 2330 engagements